SLN
NASD Silence Therapeutics PLC Sponsored ADR$10.63 ↓ -0.08 (-0.75%) Trading Down from the previous close of $10.71, $0.15 below the day’s high of $10.78
- YTD change
- +74.84%
- vs 20-day SMA
- -14.26%
- vs 200-day SMA
- +29.89%
Price ranges
Price & Performance
+4.77 (+80.30%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 69.6% away from all-time highs of $35.00
- SLN is up 75% since the beginning of the year
- SLN is up 104% over the past 12 months
- SLN is down 28% over the past 1 month
- 5% of all SLN investors are betting against SLN
SLN reads not so good: price sits above one of the two key moving averages, the 12-month move is +106.0%.
- Previous minute
- +$0.01
- Last hour
- +$0.03
- Last 5 days
- -5.26%
- vs 8-day SMA
- -5.34%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Silence Therapeutics Plc engages in the discovery, delivery, and development of ribonucleic acid (RNA) therapeutics. It also develops medicines by harnessing the body's natural mechanism of RNA interference within its cells. The company was founded on November 18, 1994 and is headquartered in London, the United Kingdom.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.